Completed
Phase 1 Study of Relative Bioavailability of PPI-668 New Tablet Versus Capsule Formulations
NCT02258321
- Conditions
- Pharmacokinetic Assessments in Healthy Volunteers
- Locations
-
- Buffalo Clinical Research Center Buffalo, New York, United States